Key Takeaways
- • KKR will acquire Integer Holdings, a medical-device outsourcing manufacturer, for $127 per share in an all-cash transaction valued at approximately $5.7 billion enterprise value, including assumption of Integer's debt.
- • The acquisition represents a significant expansion of KKR's healthcare sector exposure, adding a critical player in medical device contract manufacturing to its portfolio.
- • The transaction is expected to close by year-end 2026, with Integer becoming a privately held company following completion of the deal.
- • The all-cash structure and per-share valuation of $127 reflects KKR's conviction in Integer's business model and market position within the outsourced medical device manufacturing segment.
Summary
KKR, the global investment firm managing over $500 billion in assets, has agreed to acquire Integer Holdings Corporation, a leading medical-device outsourcing and contract manufacturing company, in an all-cash transaction announced on August 3, 2026. Under the terms of the agreement, KKR will pay Integer shareholders $127 per share in cash, representing an approximately $5.7 billion enterprise value that includes the assumption of Integer's outstanding debt.
Integer Holdings operates as a specialized outsourced manufacturer serving the medical device industry, providing contract manufacturing, assembly, and engineering services to original equipment manufacturers across multiple therapeutic categories. The acquisition positions KKR to deepen its strategic presence within the healthcare sector, a key investment theme for the firm. By acquiring Integer as a going-concern business with established customer relationships and manufacturing infrastructure, KKR gains exposure to the resilient medical device supply chain market, which benefits from consistent demand driven by aging populations and advancing therapeutic technologies.
The transaction is structured as an all-cash acquisition, eliminating equity financing risk and providing immediate certainty to Integer shareholders. The deal is expected to close by the end of 2026, subject to customary closing conditions and regulatory approvals. Upon completion, Integer Holdings will transition to private ownership under KKR management, allowing for potential operational restructuring, strategic capital allocation, and long-term value creation strategies typical of KKR's portfolio company management approach.
This acquisition reflects broader private equity interest in healthcare services and manufacturing businesses that demonstrate stable cash flows, essential customer bases, and limited economic sensitivity. For institutional investors and family offices tracking KKR's sector allocation and deal activity, the Integer transaction signals continued conviction in healthcare infrastructure plays as a core component of alternative investment strategy in the current macroeconomic environment.
Integer Holdings operates as a specialized outsourced manufacturer serving the medical device industry, providing contract manufacturing, assembly, and engineering services to original equipment manufacturers across multiple therapeutic categories. The acquisition positions KKR to deepen its strategic presence within the healthcare sector, a key investment theme for the firm. By acquiring Integer as a going-concern business with established customer relationships and manufacturing infrastructure, KKR gains exposure to the resilient medical device supply chain market, which benefits from consistent demand driven by aging populations and advancing therapeutic technologies.
The transaction is structured as an all-cash acquisition, eliminating equity financing risk and providing immediate certainty to Integer shareholders. The deal is expected to close by the end of 2026, subject to customary closing conditions and regulatory approvals. Upon completion, Integer Holdings will transition to private ownership under KKR management, allowing for potential operational restructuring, strategic capital allocation, and long-term value creation strategies typical of KKR's portfolio company management approach.
This acquisition reflects broader private equity interest in healthcare services and manufacturing businesses that demonstrate stable cash flows, essential customer bases, and limited economic sensitivity. For institutional investors and family offices tracking KKR's sector allocation and deal activity, the Integer transaction signals continued conviction in healthcare infrastructure plays as a core component of alternative investment strategy in the current macroeconomic environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.